Thomas J. Herzfeld Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-239
| Closed | -$21K | – | 269 |
|
|
2019
Q1 | $21K | Sell |
239
-12
| -5% | -$1.05K | 0.01% | 206 |
|
|
2018
Q4 | $21K | Buy |
251
+46
| +22% | +$3.85K | 0.01% | 208 |
|
|
2018
Q3 | $20K | Sell |
205
-111
| -35% | -$10.8K | 0.01% | 197 |
|
|
2018
Q2 | $30K | Hold |
316
| – | – | 0.01% | 199 |
|
|
2018
Q1 | $26K | Buy |
316
+105
| +50% | +$8.64K | 0.01% | 219 |
|
|
2017
Q4 | $19K | Sell |
211
-189
| -47% | -$17K | 0.01% | 234 |
|
|
2017
Q3 | $37K | Hold |
400
| – | – | 0.02% | 201 |
|
|
2017
Q2 | $36K | Hold |
400
| – | – | 0.02% | 197 |
|
|
2017
Q1 | $35K | Hold |
400
| – | – | 0.02% | 230 |
|
|
2016
Q4 | $33K | Hold |
400
| – | – | 0.02% | 234 |
|
|
2016
Q3 | $37K | Hold |
400
| – | – | 0.02% | 200 |
|
|
2016
Q2 | $31K | Hold |
400
| – | – | 0.02% | 243 |
|
|
2016
Q1 | $33K | Hold |
400
| – | – | 0.02% | 253 |
|
|
2015
Q4 | $42K | Hold |
400
| – | – | 0.02% | 210 |
|
|
2015
Q3 | $42K | Buy |
+400
| New | +$42K | 0.02% | 199 |
|